SPDR S&P Biotech ETF
196 hedge funds and large institutions have $3.25B invested in SPDR S&P Biotech ETF in 2015 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 55 increasing their positions, 76 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
61% less call options, than puts
Call options by funds: $525M | Put options by funds: $1.34B
295.26% less ownership
Funds ownership: 454.52% → 159.26% (-295%)
Holders
196
Holding in Top 10
6
Calls
$525M
Puts
$1.34B
Top Buyers
| 1 | +$329M | |
| 2 | +$109M | |
| 3 | +$46.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$34.2M |
| 5 |
TI
Think Investments
San Francisco,
California
|
+$22.4M |
Top Sellers
| 1 | -$103M | |
| 2 | -$57.7M | |
| 3 | -$24.8M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$22.1M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$17.1M |